Literature DB >> 27495951

Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes.

Murat Atabey Ozer1, Nihat Polat2, Serkan Ozen3, Tevfik Ogurel4, Hakan Parlakpinar5, Nigar Vardi6.   

Abstract

The aim of the current study was to evaluate the effect of apocynin (APO) on the development of proliferative vitreoretinopathy (PVR). New Zealand-type male rabbits were randomly grouped into three as follows: (1) Sham group rabbits which were applied intraperitoneal (i.p.) vehicle without PVR; (2) PVR group rabbits where PVR was created and an i.p. vehicle was administered for 21 successive days; (3) PVR + APO group rabbits where PVR was created and i.p. APO was administered for 21 successive days. Fundus examination was conducted with an indirect ophthalmoscope before starting the experiments and at each visit afterwards. At the end of the work, the rabbits were sacrificed under high-dose anesthesia and then eye tissues were taken for histopathological analyses. In the PVR + APO group, histopathologic and ophthalmoscopic examination revealed significant decrease in PVR formation. As the result, it has been observed that APO at least partially inhibits PVR formation.

Entities:  

Keywords:  Apocynin; Eye; Proliferative vitreoretinopathy; Rabbit

Mesh:

Substances:

Year:  2016        PMID: 27495951     DOI: 10.1007/s10792-016-0318-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  35 in total

1.  Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants.

Authors:  E Anitua
Journal:  Int J Oral Maxillofac Implants       Date:  1999 Jul-Aug       Impact factor: 2.804

2.  The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization.

Authors:  Elizabeth Monaghan-Benson; John Hartmann; Aleksandr E Vendrov; Steve Budd; Grace Byfield; Augustus Parker; Faisal Ahmad; Wei Huang; Marschall Runge; Keith Burridge; Nageswara Madamanchi; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

3.  Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.

Authors:  Mohamed Al-Shabrawey; Manuela Bartoli; Azza B El-Remessy; Daniel H Platt; Sue Matragoon; M Ali Behzadian; Robert W Caldwell; Ruth B Caldwell
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

4.  Wendell L. Hughes Lecture. Wound healing.

Authors:  R B Wilkins; D R Kulwin
Journal:  Ophthalmology       Date:  1979-04       Impact factor: 12.079

5.  5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite.

Authors:  M Blumenkranz; E Hernandez; A Ophir; E W Norton
Journal:  Ophthalmology       Date:  1984-02       Impact factor: 12.079

Review 6.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

7.  Protective and therapeutic effect of apocynin on bleomycin-induced lung fibrosis in rats.

Authors:  Talat Kilic; Hakan Parlakpinar; Elif Taslidere; Sedat Yildiz; Alaadin Polat; Nigar Vardi; Cemil Colak; Hilal Ermis
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

8.  Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in rats.

Authors:  Maha M El-Sawalhi; Lamiaa A Ahmed
Journal:  Chem Biol Interact       Date:  2013-11-26       Impact factor: 5.192

9.  Taxol treatment of experimental proliferative vitreoretinopathy.

Authors:  S A Daniels; K G Coonley; M O Yoshizumi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 10.  The neuroprotective effects of apocynin.

Authors:  Agnes Simonyi; Peter Serfozo; Tareq M Lehmidi; Jiankun Cui; Zezong Gu; Dennis B Lubahn; Albert Y Sun; Grace Y Sun
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.